The Oncology Institute, Inc. (TOI) Q2 FY26 Earnings Call

Positive adjusted EBITDA at the top of guidance, alongside raised full-year outlook ([4],[8]).

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-07-27
Length29 minutes
EPS$-0.08
EPS consensus$-0.07
Revenue$161.3M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All TOI earnings ยท Back to TOI overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.